ENOV

Enovis Corporation NYSE

Industrials ·Industrial - Machinery ·US · enovis.com

$23.34

Mkt Cap $1.3B

52w Low $21.00 13.9% of range 52w High $37.85

50d MA $23.72 200d MA $27.18

P/E (TTM) -1.1x

EV/EBITDA -3.4x

P/B 0.9x

Debt/Equity 0.9x

ROE -79.5%

P/FCF 76.0x

RSI (14) —

ATR (14) —

Beta 1.59

50d MA $23.72

200d MA $27.18

Avg Volume 989.5K

About

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting fro…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	0.81	0.95	+17.3%	25.42	+0.3%	+0.2%	+1.1%	-0.5%	+1.5%	-4.3%	—
Nov 6, 2025	AMC	0.67	0.75	+11.9%	28.42	-1.7%	-1.3%	+6.5%	+10.9%	+9.9%	+8.6%	—
Aug 7, 2025	AMC	0.74	0.79	+6.8%	28.52	+0.0%	-0.3%	-1.4%	+0.8%	+3.8%	+1.1%	—
May 8, 2025	AMC	0.74	0.81	+9.5%	33.08	-1.1%	-0.1%	+10.6%	+12.9%	+9.5%	+8.0%	—
Feb 26, 2025	AMC	0.92	0.98	+6.5%	40.00	-0.3%	-4.7%	-3.4%	-5.3%	-8.4%	-6.0%	—
Nov 6, 2024	AMC	0.63	0.73	+15.9%	46.90	-1.2%	+2.0%	-1.0%	+1.0%	+0.0%	-1.0%	—
Aug 7, 2024	AMC	0.60	0.62	+3.3%	40.57	+2.4%	+7.4%	+7.0%	+4.5%	+6.6%	+6.0%	—
May 2, 2024	AMC	0.50	0.50	+0.0%	52.13	+0.5%	-1.6%	-2.3%	+0.2%	-2.8%	-2.1%	—
Feb 22, 2024	AMC	0.76	0.79	+3.9%	63.80	-0.7%	-1.5%	-3.5%	-3.7%	-4.7%	-6.3%	—
Nov 7, 2023	AMC	0.53	0.56	+5.7%	48.33	+0.4%	-0.2%	-2.1%	-1.0%	-0.2%	+4.0%	—
Aug 3, 2023	AMC	0.53	0.61	+15.1%	58.96	+1.6%	+0.5%	+0.1%	-2.1%	-4.1%	-5.3%	—
May 4, 2023	AMC	0.37	0.44	+18.9%	57.54	+1.1%	-0.2%	-1.1%	-2.1%	-2.7%	-3.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 6	Evercore ISI	Maintains	Outperform → Outperform	—	$22.64	$22.33	-1.4%	+0.5%	-0.5%	+5.1%	+6.0%	+7.9%
Feb 26	BTIG	Maintains	Buy → Buy	—	$22.32	$22.62	+1.3%	+13.9%	+14.1%	+15.1%	+13.3%	+15.5%
Feb 26	Needham	Maintains	Buy → Buy	—	$22.32	$22.62	+1.3%	+13.9%	+14.1%	+15.1%	+13.3%	+15.5%
Dec 17	Canaccord Genuity	Maintains	Buy → Buy	—	$26.07	$26.63	+2.1%	+4.9%	+4.8%	+2.6%	+4.3%	+0.9%
Nov 7	Wells Fargo	Maintains	Overweight → Overweight	—	$28.42	$27.95	-1.7%	-1.3%	+6.5%	+10.9%	+9.9%	+8.6%
Aug 8	Wells Fargo	Maintains	Overweight → Overweight	—	$28.52	$28.53	+0.0%	-0.3%	-1.4%	+0.8%	+3.8%	+1.1%
Aug 8	UBS	Maintains	Buy → Buy	—	$28.52	$28.53	+0.0%	-0.3%	-1.4%	+0.8%	+3.8%	+1.1%
Aug 8	Canaccord Genuity	Maintains	Buy → Buy	—	$28.52	$28.53	+0.0%	-0.3%	-1.4%	+0.8%	+3.8%	+1.1%
Aug 7	Needham	Maintains	Buy → Buy	—	$25.76	$27.58	+7.1%	+10.7%	+10.4%	+9.1%	+11.6%	+14.9%
Jul 8	Evercore ISI	Maintains	Outperform → Outperform	—	$33.02	$33.30	+0.8%	+5.2%	+7.7%	+8.8%	+3.1%	-3.2%
May 14	Canaccord Genuity	Maintains	Buy → Buy	—	$37.35	$37.05	-0.8%	-3.0%	-4.3%	-3.5%	-5.0%	-7.7%
May 9	Needham	Maintains	Buy → Buy	—	$33.08	$32.72	-1.1%	-0.1%	+10.6%	+12.9%	+9.5%	+8.0%
May 9	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$33.08	$32.72	-1.1%	-0.1%	+10.6%	+12.9%	+9.5%	+8.0%
Apr 9	Needham	Maintains	Buy → Buy	—	$30.66	$30.00	-2.2%	+11.6%	+4.7%	+4.4%	+5.4%	+2.7%
Apr 2	Needham	Maintains	Buy → Buy	—	$37.18	$35.81	-3.7%	-0.5%	-9.1%	-12.5%	-12.6%	-17.5%
Feb 27	Needham	Maintains	Buy → Buy	—	$40.00	$39.88	-0.3%	-4.7%	-3.4%	-5.3%	-8.4%	-6.0%
Nov 7	Needham	Maintains	Buy → Buy	—	$46.90	$46.34	-1.2%	+2.0%	-1.0%	+1.0%	+0.0%	-1.0%
Oct 1	Evercore ISI	Maintains	Outperform → Outperform	—	$43.05	$42.75	-0.7%	-3.7%	-5.1%	-7.2%	-5.5%	-8.0%
Aug 8	JP Morgan	Maintains	Neutral → Neutral	—	$40.57	$41.54	+2.4%	+7.4%	+7.0%	+4.5%	+6.6%	+6.0%
Aug 8	Needham	Maintains	Buy → Buy	—	$40.57	$41.54	+2.4%	+7.4%	+7.0%	+4.5%	+6.6%	+6.0%
Jul 2	Evercore ISI	Maintains	Outperform → Outperform	—	$44.35	$44.35	+0.0%	+0.8%	+0.2%	+1.1%	+0.0%	-1.4%
May 3	Needham	Maintains	Buy → Buy	—	$52.13	$52.37	+0.5%	-1.6%	-2.3%	+0.2%	-2.8%	-2.1%
Apr 10	Needham	Maintains	Buy → Buy	—	$62.43	$61.79	-1.0%	-4.0%	-4.2%	-6.2%	-9.0%	-9.5%
Feb 23	Wells Fargo	Maintains	Overweight → Overweight	—	$63.80	$63.38	-0.7%	-1.5%	-3.5%	-3.7%	-4.7%	-6.3%
Feb 23	Needham	Maintains	Buy → Buy	—	$63.80	$63.38	-0.7%	-1.5%	-3.5%	-3.7%	-4.7%	-6.3%
Feb 23	Canaccord Genuity	Maintains	Buy → Buy	—	$63.80	$63.38	-0.7%	-1.5%	-3.5%	-3.7%	-4.7%	-6.3%
Jan 8	Needham	Maintains	Buy → Buy	—	$56.21	$56.88	+1.2%	+2.0%	+3.1%	+3.9%	+3.4%	+3.0%
Dec 20	Canaccord Genuity	Maintains	Buy → Buy	—	$55.45	$55.90	+0.8%	-0.9%	+2.0%	+2.9%	+2.5%	+2.1%
Dec 15	Needham	Maintains	Buy → Buy	—	$53.70	$54.34	+1.2%	-0.1%	+0.7%	+3.3%	+2.3%	+5.3%
Nov 8	Needham	Maintains	Buy → Buy	—	$48.33	$48.52	+0.4%	-0.2%	-2.1%	-1.0%	-0.2%	+4.0%
Oct 20	Needham	Maintains	Buy → Buy	—	$44.86	$44.58	-0.6%	-0.9%	+1.5%	+2.0%	-1.5%	-2.7%
Aug 4	Needham	Maintains	Buy → Buy	—	$58.96	$59.92	+1.6%	+0.5%	+0.1%	-2.1%	-4.1%	-5.3%
Aug 4	Baird	Maintains	Outperform → Outperform	—	$58.96	$59.92	+1.6%	+0.5%	+0.1%	-2.1%	-4.1%	-5.3%
May 12	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$55.79	$57.17	+2.5%	+1.3%	+2.6%	+1.7%	+0.0%	-1.3%
May 5	Baird	Maintains	Outperform → Outperform	—	$57.54	$58.15	+1.1%	-0.2%	-1.1%	-2.1%	-2.7%	-3.0%
Mar 28	Canaccord Genuity	Maintains	Buy → Buy	—	$50.32	$49.93	-0.8%	+0.2%	+3.7%	+5.1%	+6.3%	+6.3%
Feb 24	Baird	Maintains	Outperform → Outperform	—	$57.62	$56.64	-1.7%	-3.1%	-0.7%	+0.0%	-0.5%	-0.7%
Nov 3	Baird	Maintains	Outperform → Outperform	—	$47.86	$46.45	-2.9%	+6.8%	+7.8%	+11.2%	+10.2%	+8.3%
Oct 26	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$48.57	$48.52	-0.1%	+2.5%	+0.8%	+3.1%	+1.8%	+2.0%
Oct 12	Jefferies	Maintains	Buy → Buy	—	$44.83	$45.22	+0.9%	+0.6%	+3.4%	+0.3%	+6.0%	+6.3%
Oct 11	Goldman Sachs	Maintains	Buy → Buy	—	$44.86	$45.11	+0.6%	-0.1%	+0.5%	+3.3%	+0.3%	+6.0%
Sep 12	Evercore ISI	Maintains	Outperform → Outperform	—	$51.55	$52.41	+1.7%	+6.0%	+0.8%	+2.4%	+2.0%	-0.5%
Sep 12	Canaccord Genuity	Maintains	Buy → Buy	—	$51.55	$52.41	+1.7%	+6.0%	+0.8%	+2.4%	+2.0%	-0.5%
Jun 28	Argus	Maintains	Hold → Hold	—	$58.99	$58.54	-0.8%	-4.3%	-5.6%	-6.8%	-5.1%	-5.7%
Jun 16	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$61.20	$59.90	-2.1%	-6.6%	-7.7%	-8.8%	-9.7%	-9.5%
Apr 21	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$70.47	$70.35	-0.2%	-3.0%	-4.9%	-4.5%	-5.6%	-7.9%

Recent Filings

8-K

Enovis Corporation -- 8-K Filing

Enovis Corporation reported 4% year-over-year growth in Prevention Recovery sales for Q4 2025, demonstrating modest organic expansion in its medical technology segment.

Feb 26

8-K

Middleby Corp -- 8-K Filing

Middleby Corp appointed Christopher Hix to its board of directors, expanding its governance structure with a new board member.

Feb 4

Data updated apr 25, 2026 7:11am · Source: massive.com